Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.
about
Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cellsIsolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigensTargeting androgen receptor and JunD interaction for prevention of prostate cancer progressionRhoA as a mediator of clinically relevant androgen action in prostate cancer cellsSmall molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancerChanges in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancerApplication of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progressionMolecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancerEmerging mechanisms of resistance to androgen receptor inhibitors in prostate cancerTargeting the SR-B1 Receptor as a Gateway for Cancer Therapy and ImagingExpression and functional role of orphan receptor GPR158 in prostate cancer growth and progressionProstatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epitheliumStilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cellsSubverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cellsRegions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells.The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.Transcriptional activity of c-Jun is critical for the suppression of AR function.A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death.Can cancer cells transform normal host cells into malignant cells?Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor.The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidenceFOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/BakGamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancerAdvances in preclinical investigation of prostate cancer gene therapy.Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristicsDTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cellsA novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells.Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration.Transforming growth factor-beta1 and prostate cancer.The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cellsErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cellsRole of transforming growth factor-beta1 in prostate cancer.Digoxin inhibits blood vessel density and HIF-1a expression in castration-resistant C4-2 xenograft prostate tumors.The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
P2860
Q24292284-12A46C58-7CC1-44BD-840E-349545B122C6Q24311489-01FED657-F432-43CB-9B91-5A15AF859705Q24339416-9634939B-58E5-4165-9314-2920A1F53CF8Q24618899-E0B71FAD-4B61-4FF8-9BD5-A5B9E8B259F2Q24620356-CA770A9D-9FE2-43C2-8F9F-12DDC174E2D5Q24807354-9DC5AB8D-5693-4858-A2E5-60581E2566CDQ24813698-76F19821-0083-45D9-BF27-C0AE571CDEC6Q26739708-3E691970-4593-41BC-93E8-33FA657404ABQ26777310-72A0DCB4-8A78-4E85-90CB-9276482B9198Q28070244-03EB4477-8BF6-4C57-92B4-21A1943D5AFCQ28257270-ED3B0A78-C0D2-43DF-A859-F6F3E3EF9566Q28508802-E2F9CA6D-D8D1-4AF2-9CA4-4784D8B6CAFDQ28539233-5F0E974E-7266-4828-96E5-5B05FBF62EE1Q28541919-11165333-0215-4114-B94F-D0FA1DE84156Q30306146-30919179-EC4A-4245-BBF7-764F01D43807Q30307781-AC363252-C9C1-45C9-9CCC-A4C61DB28A6EQ30412500-593355B1-0CA4-4D2D-A02A-57E5097F4D7FQ30423585-5FA55175-945B-403B-A04F-C0F62294B64AQ30438655-9FFA3EB5-92BB-4D18-9A44-FF7EA3DEB8FFQ30438661-7926795D-E3C7-4106-91F8-DBF2383EEA9AQ30446159-CD67EA38-9717-4045-BD4F-E81528F591EEQ30472489-9A0C3431-8345-40BE-A7D4-79F9D4A0C909Q30528764-94F3E874-7420-48CC-B34C-5AF3E6FD0BBEQ30845020-86DA53F2-B23A-4F70-B9A0-474018B136C9Q31083556-54CE4769-CAC9-4F61-98E6-C9A4A3532F78Q33587990-0C3D52FE-0A06-4E31-93D8-8C5BC535D076Q33644807-52E5B1D7-CFF4-4BCB-9D1D-EEBE4FED1120Q33677054-0C63672A-7983-4AAE-AF28-1F5E74FA6BA8Q33705239-A95CFB2C-7022-4826-9C70-25763F7513C4Q33732592-F6C92E7A-5DF1-4267-BDB7-D9417082B762Q33805578-CA5C70A7-53BC-4270-BC03-7E89039F5DD8Q33905704-17470BD3-3E03-4903-95E4-E9458C836342Q33958982-4353ACA7-C3D2-490F-A3E5-6E991791E6B0Q33973701-F2491D95-5A6D-485B-A6CC-8D27A4C1417BQ34022799-261A449C-2481-4028-AFAB-D79486F71A5CQ34090944-E979DE65-90E1-462D-9DB0-EAE42231E564Q34110474-73E38420-769B-404D-9DCE-75A12937D670Q34136505-5605EEAF-8061-4D34-9C54-4C872A77505BQ34140823-7573BC49-BBED-409E-8854-C08776E296A1Q34227747-2BD8DF37-340D-4367-99CC-91F05A64ADD4
P2860
Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Derivation of androgen-indepen ...... s: role of bone stromal cells.
@ast
Derivation of androgen-indepen ...... s: role of bone stromal cells.
@en
Derivation of androgen-indepen ...... s: role of bone stromal cells.
@nl
type
label
Derivation of androgen-indepen ...... s: role of bone stromal cells.
@ast
Derivation of androgen-indepen ...... s: role of bone stromal cells.
@en
Derivation of androgen-indepen ...... s: role of bone stromal cells.
@nl
prefLabel
Derivation of androgen-indepen ...... s: role of bone stromal cells.
@ast
Derivation of androgen-indepen ...... s: role of bone stromal cells.
@en
Derivation of androgen-indepen ...... s: role of bone stromal cells.
@nl
P2093
P4510
P356
P1476
Derivation of androgen-indepen ...... s: role of bone stromal cells.
@en
P2093
P304
P356
10.1002/IJC.2910570319
P577
1994-05-01T00:00:00Z